—
Wednesday, August 24, 2022
The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration established the Eng...
Read more
—
Tuesday, August 23, 2022
According to a report published in eJHaem, a loss of balance along with associated falls appears to be a...
Read more
—
Monday, August 22, 2022
Results from a recent real-world analysis suggest possible benefits with early use of daratumumab-based t...
Read more
Cancer Action Now was launch on May 24, an alliance of 28 health care organizations, which includes Myelo...
Read more
Myeloma Canada, along with 24 signatories, wrote a letter to the Federal Health Minister, Jean-Yves Duclo...
Read more
This past month along with the CANcertainty coalition, Myeloma Canada continued to advocate for the needs...
Read more